Report Summary: The global angiotensin receptor antagonists market is poised for significant growth, with a projected value of US$ 12.0 billion by 2032 and a steady compound annual growth rate (CAGR) of 3.6%. This expansion is primarily driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Angiotensin receptor antagonists, known for their efficacy and safety, […]
